When the investor relations folks at Johnson & Johnson’s New Brunswick, N.J, headquarters kicked out the company’s earnings Tuesday morning, it marked the beginning of yet another quarterly earnings season — and another peek at how the medical device industry has withstood the worst financial crisis in generations.
For JNJ the news was good; sales of medical devices were up 4.2 percent domestically and even beat its pharmaceutical division’s numbers for just the second time in a decade. But will the rest of the industry show similar signs of health?